Drug Profile
Tc 99m RP 128
Alternative Names: 99mTc RP 128Latest Information Update: 27 Aug 2007
Price :
$50
*
At a glance
- Originator Bracco
- Class Peptide diagnostics; Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Crohn's disease; Rheumatoid arthritis
Most Recent Events
- 27 Aug 2007 Discontinued - Phase-II for Crohn's disease diagnosis and rheumatoid arthritis diagnosis in Canada (unspecified route)
- 27 Aug 2007 Discontinued - Phase-II for Crohn's disease diagnosis and rheumatoid arthritis diagnosis in European Union (unspecified route)
- 28 Jan 1999 Phase-II clinical trials for Crohn's disease diagnosis and rheumatoid arthritis diagnosis in Canada (unspecified route)